Personalized Oncogenomics (POG) Program of British Columbia

计划入组 5,000 人 · 首次发布于 2014 年 6 月 4 日

British Columbia Prescriber Feedback Program - Antimicrobial Resistance

计划入组 7,626 人 · 首次发布于 2026 年 2 月 24 日

Social Determinants in Chronic Disease in British Columbia

计划入组 300 人 · 首次发布于 2014 年 7 月 29 日

difluorosialic acid derivatives (University of British Columbia)

androgen receptor inhibitor (University of British Columbia)

Erg protein inhibitor (University of British Columbia)

University of British Columbia

Canada

British Columbia Cancer Agency

University of Northern British Columbia

Canada

British Columbia Opens First Phase 1 Clinical Trials Unit for Non-Oncology Treatments

BIOQuébec and Life Sciences British Columbia Form Strategic Alliance to Strengthen Canada's Life Sciences Ecosystem

British Columbia Restricts Sales of Diabetes Drugs Tirzepatide and Dulaglutide to Combat Weight Loss-Driven Shortages